Pharmaceutical

What’s next for AAV gene therapies in 2024?

Upcoming regulatory events for pipeline AAV gene therapies, with a focus on neuromuscular and blood disorders, are setting high expectations for the space in 2024.

Mar 11, 2024 - 00:00
What’s next for AAV gene therapies in 2024?
Upcoming regulatory events for pipeline AAV gene therapies, with a focus on neuromuscular and blood disorders, are setting high expectations for the space in 2024.
Read the original article

Tags:

Previous Article

Opinion: STAT readers on new CDC Covid guidelines, weight loss drugs and mental ...

Next Article

Have metalenses expanded their reach into the ultraviolet region?

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

AWT-020 by Anwita Biosciences for Sarcomas: Likelihood ...

Dec 26, 2023

STAT+: Here are the worst biopharma CEOs of 2023

STAT+: Here are the worst biopharma CEOs of 2023

Dec 19, 2023

STAT+: Medical device maker Teleflex to acquire urology company Palette Life Sciences for $600 million

STAT+: Medical device maker Teleflex to acquire urology...

Jul 26, 2023